000129106 001__ 129106
000129106 005__ 20240228143409.0
000129106 0247_ $$2doi$$a10.1007/s00330-015-4195-0
000129106 0247_ $$2pmid$$apmid:26767378
000129106 0247_ $$2ISSN$$a0938-7994
000129106 0247_ $$2ISSN$$a1432-1084
000129106 0247_ $$2ISSN$$a1613-3749
000129106 0247_ $$2ISSN$$a1613-3757
000129106 0247_ $$2altmetric$$aaltmetric:5001694
000129106 037__ $$aDKFZ-2017-05111
000129106 041__ $$aeng
000129106 082__ $$a610
000129106 1001_ $$00000-0002-6226-1252$$aMai, Elias K$$b0
000129106 245__ $$aAssociation between magnetic resonance imaging patterns and baseline disease features in multiple myeloma: analyzing surrogates of tumour mass and biology.
000129106 260__ $$aBerlin$$bSpringer$$c2016
000129106 3367_ $$2DRIVER$$aarticle
000129106 3367_ $$2DataCite$$aOutput Types/Journal article
000129106 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1530621376_20860
000129106 3367_ $$2BibTeX$$aARTICLE
000129106 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000129106 3367_ $$00$$2EndNote$$aJournal Article
000129106 520__ $$aTo assess associations between bone marrow infiltration patterns and localization in magnetic resonance imaging (MRI) and baseline clinical/prognostic parameters in multiple myeloma (MM).We compared baseline MM parameters, MRI patterns and localization of focal lesions to the mineralized bone in 206 newly diagnosed MM patients.A high tumour mass (represented by International Staging System stage III) was significantly associated with severe diffuse infiltration (p = 0.015) and a higher number of focal lesions (p = 0.006). Elevated creatinine (p = 0.003), anaemia (p < 0.001) and high LDH (p = 0.001) correlated with severe diffuse infiltration. A salt and pepper diffuse pattern had a favourable prognosis. A higher degree of destruction of mineralized bone (assessed by X-ray or computed tomography) was associated with an increasing number of focal lesions on MRI (p < 0.001). Adverse cytogenetics (del17p/gain1q21/t(4;14)) were associated with diffuse infiltration (p = 0.008). The presence of intraosseous focal lesions exceeding the mineralized bone had a borderline significant impact on prognosis.Diffuse bone marrow infiltration on MRI correlates with adverse cytogenetics, lowered haemoglobin values and high tumour burden in newly diagnosed MM whereas an increasing number of focal lesions correlates with a higher degree of bone destruction. Focal lesions exceeding the cortical bone did not adversely affect the prognosis.• Diffuse MRI correlates with adverse cytogenetics, lowered haemoglobin and high tumour burden. • Higher numbers of MRI focal lesions correlate with increasing degree of bone destruction. • Focal lesions exceeding the cortical bone borderline significantly influence survival. • Moderate/severe diffuse infiltration and more than 23 focal lesions adversely affect survival.
000129106 536__ $$0G:(DE-HGF)POF3-315$$a315 - Imaging and radiooncology (POF3-315)$$cPOF3-315$$fPOF III$$x0
000129106 588__ $$aDataset connected to CrossRef, PubMed,
000129106 7001_ $$0P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f$$aHielscher, Thomas$$b1$$udkfz
000129106 7001_ $$aKloth, Jost K$$b2
000129106 7001_ $$0P:(DE-HGF)0$$aMerz, Maximilian$$b3
000129106 7001_ $$aShah, Sofia$$b4
000129106 7001_ $$aHillengass, Michaela$$b5
000129106 7001_ $$aWagner, Barbara$$b6
000129106 7001_ $$aHose, Dirk$$b7
000129106 7001_ $$0P:(DE-He78)1cb537e833afd985097ccfaddffb2ef3$$aRaab, M. S.$$b8$$udkfz
000129106 7001_ $$aJauch, Anna$$b9
000129106 7001_ $$0P:(DE-He78)3e76653311420a51a5faeb80363bd73e$$aDelorme, Stefan$$b10$$udkfz
000129106 7001_ $$aGoldschmidt, Hartmut$$b11
000129106 7001_ $$0P:(DE-He78)5d10a98475a036b2a1ad3c2316d4b3ab$$aWeber, Marc-André$$b12$$udkfz
000129106 7001_ $$0P:(DE-He78)7ccc574e713526d2a22d7acb9b2248c5$$aHillengass, Jens$$b13$$eLast author$$udkfz
000129106 773__ $$0PERI:(DE-600)1472718-3$$a10.1007/s00330-015-4195-0$$gVol. 26, no. 11, p. 3939 - 3948$$n11$$p3939 - 3948$$tEuropean radiology$$v26$$x1432-1084$$y2016
000129106 909CO $$ooai:inrepo02.dkfz.de:129106$$pVDB
000129106 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000129106 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000129106 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)1cb537e833afd985097ccfaddffb2ef3$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000129106 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)3e76653311420a51a5faeb80363bd73e$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000129106 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)5d10a98475a036b2a1ad3c2316d4b3ab$$aDeutsches Krebsforschungszentrum$$b12$$kDKFZ
000129106 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)7ccc574e713526d2a22d7acb9b2248c5$$aDeutsches Krebsforschungszentrum$$b13$$kDKFZ
000129106 9131_ $$0G:(DE-HGF)POF3-315$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImaging and radiooncology$$x0
000129106 9141_ $$y2016
000129106 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000129106 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEUR RADIOL : 2015
000129106 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000129106 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000129106 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000129106 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000129106 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000129106 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000129106 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000129106 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000129106 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000129106 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000129106 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000129106 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lBiostatistik$$x0
000129106 9201_ $$0I:(DE-He78)E010-20160331$$kE010$$lRadiologie$$x1
000129106 9201_ $$0I:(DE-He78)G330-20160331$$kG330$$lKKE Molekulare Hämatologie/Onkologie$$x2
000129106 980__ $$ajournal
000129106 980__ $$aVDB
000129106 980__ $$aI:(DE-He78)C060-20160331
000129106 980__ $$aI:(DE-He78)E010-20160331
000129106 980__ $$aI:(DE-He78)G330-20160331
000129106 980__ $$aUNRESTRICTED